How bringing home your job stresses can affect your dog
PARIS : After a stormy meeting, an urgent job to finish, or tension with a colleague, your dog may greet you as usual when you get home. But something might not feel right: your pet may seem agitated, pace back and forth, and whine softly.
Too preoccupied with your work worries, you fail to make the connection: your stress has already contaminated your faithful companion.
This scene, experienced by millions of 'dog parents', illustrates the conclusions of a recent study conducted by researchers at Washington State University and published in Scientific Reports. It shows that our dogs feel our work-related stress directly, especially when we struggle to mentally unplug from our preoccupations at work.
The researchers surveyed 85 working adults who own dogs. Participants were asked to rate their level of work stress and their tendency to ruminate, and they were asked to rate their pet's stress according to specific behavioral indicators.
The results showed that the dogs displayed behaviours indicative of anxiety when their owners brooded over their work problems.
However, the study reveals an important nuance: it's not so much the high level of work-related stress that affects the animal but rather this tendency to ruminate – that is, to mentally transport work concerns into the privacy of the home.
When we carry our professional worries beyond office hours, we remain tense and distracted. Body language, tone of voice and general behaviour betray this inner tension – signals that dogs pick up with remarkable acuity.
Emotional contagion
A dog's ability to decode emotional states is explained by a scientifically recognised mechanism: emotional contagion. These four-legged companions are absolute masters in the art of deciphering non-verbal signals, which means they can 'catch' their master's emotions.
Dogs excel at reading facial expressions and picking up changes in tone and posture, which makes them highly attuned to their owners' work stress.
Aim to spend quality time with your dog by being fully present, without phones or distractions. (Envato Elements pic)
This phenomenon goes far beyond simple observation. The animal perceives subtle changes in breathing, gestures or body language, creating a surprising emotional synchronisation with its owner. This extraordinary sensitivity explains why our pets sometimes seem to sense our moods before we are even conscious of them ourselves.
In light of this, the study authors suggest a number of ways of shielding animals from this emotional contagion. In particular, they recommend practising mindfulness, through deep-breathing exercises or meditation, to truly leave stress at the office.
Establishing end-of-day rituals, such as a short walk or a change of clothes, can also mentally signal that the working day is coming to an end.
The idea of spending quality time with your dog by being fully present, without phones or distractions, is another key recommendation. Monitoring your pet's body language and maintaining a calm home environment also help to create a reassuring haven for the animal.
Finally, the researchers do not hesitate to suggest seeking professional help if stress becomes unmanageable.
Ultimately, this study reminds us of a fundamental truth: our dogs don't know our jobs or our bosses' demands, but they know perfectly well when we're upset or distracted. In spite of themselves, our four-legged companions offer us a lesson in professional wisdom – the importance of leaving work at work.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
12 hours ago
- Malay Mail
From painkillers to antibiotics: Five medicines that could harm your hearing
LONDON, July 22 — When we think about the side effects of medicines, we might think of nausea, fatigue or dizziness. But there's another, lesser-known risk that can have lasting — and sometimes permanent — consequences: hearing loss. A wide range of prescription and over-the-counter drugs are known to be ototoxic, meaning they can damage the inner ear and affect hearing or balance. Ototoxicity refers to drug or chemical-related damage to the cochlea, which affects hearing, and the vestibular system, which controls balance. Symptoms can include tinnitus (ringing in the ears), hearing loss (often starting with high-frequency sounds), dizziness or balance problems or a sensation of fullness in the ears. These effects can be temporary or permanent, depending on the drug involved, the dose and duration and a person's susceptibility. The inner ear is highly sensitive, and most experts believe ototoxic drugs cause damage by harming the tiny hair cells in the cochlea or disrupting the fluid balance in the inner ear. Once these hair cells are damaged, they don't regenerate — making hearing loss irreversible in many cases. Around 200 medicines are known to have ototoxic effects. Here are some of the most commonly used drugs to watch out for: 1. Antibiotics Aminoglycoside antibiotics like gentamicin, tobramycin and streptomycin are typically prescribed for serious infections such as sepsis, meningitis, or tuberculosis — conditions where prompt, aggressive treatment can be lifesaving. In these cases, the benefits often outweigh the potential risk of hearing loss. These drugs, usually given intravenously, are among the most well-documented ototoxic medications. They can cause irreversible hearing loss, particularly when used in high doses or over extended periods. Some people may also be genetically more vulnerable to these effects. These drugs linger in the inner ear for weeks or even months, meaning damage can continue after treatment has ended. Other antibiotics to be aware of include macrolides (such as erythromycin and azithromycin) and vancomycin, which have also been linked to hearing problems, particularly in older adults or people with kidney issues. 2. Heart medicines Loop diuretics like furosemide and bumetanide are commonly used to manage heart failure or high blood pressure. When given in high doses or intravenously, they can cause temporary hearing loss by disrupting the fluid and electrolyte balance in the inner ear. Around 3 per cent of users may experience ototoxicity. Some blood pressure medications have also been linked to tinnitus. These include ACE inhibitors — drugs like ramipril that help relax blood vessels by blocking a hormone called angiotensin, making it easier for the heart to pump blood — and calcium-channel blockers like amlodipine, which reduce blood pressure by preventing calcium from entering the cells of the heart and blood vessel walls. While these associations have been observed, more research is needed to fully understand the extent of their effect on hearing. 3. Chemotherapy Certain chemotherapy drugs, especially those containing platinum — like cisplatin and carboplatin — are known to be highly ototoxic. Cisplatin, often used to treat testicular, ovarian, breast, head and neck cancers, carries a significant risk of permanent hearing loss. That risk increases when radiation is also directed near the head or neck. Up to 60 per cent of patients treated with cisplatin experience some degree of hearing loss. Researchers are exploring ways to reduce risk by adjusting dosage or frequency without compromising the drug's effectiveness. 4. Painkillers High doses of common pain relievers, including aspirin, NSAIDs — non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen, commonly used to relieve pain, inflammation and fever — and even paracetamol, have been linked to tinnitus and hearing loss. A large study found that women under 60 who regularly took moderate-dose aspirin (325 mg or more, six to seven times per week) had a 16 per cent higher risk of developing tinnitus. This link was not seen with low-dose aspirin (100 mg or less). Frequent use of NSAIDs as well as paracetamol was also associated with a nearly 20 per cent increased risk of tinnitus, particularly in women who used these medications often. Another study linked long-term use of these painkillers to a higher risk of hearing loss, especially in men under 60. In most cases, tinnitus and hearing changes resolve once the medication is stopped — but these side effects typically occur after prolonged, high-dose use. 5. Antimalarial drugs Drugs like chloroquine and quinine — used to treat malaria and leg cramps — can cause reversible hearing loss and tinnitus. One study found that 25-33 per cent of people with hearing loss had previously taken one of these drugs. Hydroxychloroquine, used to treat lupus and rheumatoid arthritis, has a similar chemical structure and poses a similar risk. While some people recover after stopping the drug, others may experience permanent damage, particularly after long-term or high-dose use. People with pre-existing hearing loss, kidney disease, or genetic susceptibility face higher risks — as do those taking multiple ototoxic drugs at once. Children and older adults may also be more vulnerable. If you're prescribed one of these medications for a serious condition like cancer, sepsis or tuberculosis, the benefits usually outweigh the risks. But it's still wise to be informed. Ask your doctor or pharmacist if your medicine carries a risk to hearing or balance. If you experience ringing in your ears, dizziness, or muffled hearing, report it promptly. — Reuters
Malay Mail
15 hours ago
- Malay Mail
Astronomers spot hidden companion star orbiting blazing Betelgeuse
PARIS, July 22 — Since at least the time of the ancient Egyptians, people across the world have gazed up in awe at Betelgeuse, one of the brightest stars blazing in the night sky. Now astronomers have discovered that this red supergiant, known to many as the hunter's shoulder in the Orion constellation, is being orbited by a much smaller companion star, a study said on Monday. It is not the first time Betelgeuse has surprised stargazers. Seemingly out of nowhere, the giant star dramatically dimmed for five months between 2019 and 2020, leading some scientists to suggest it could soon die in an epic supernova explosion. Further observations revealed that this event — known as the 'Great Dimming' — was actually caused by material ejected from the surface that cooled part of the star, creating a dust cloud that blocked its light. But scientists could still not explain why Betelgeuse's brightness changes regularly, both on a 400-day cycle and another that lasts nearly six years. In a paper titled 'A Buddy for Betelgeuse' published in December, some researchers theorised that the longer variation could be caused by a hidden small star orbiting the behemoth. Astronomers using the Gemini North telescope in Hawaii have now discovered this elusive companion, according to a new study in The Astrophysical Journal Letters. Little buddy This companion has a mass around 1.5 times greater than our Sun, the research estimated. That means it is dwarfed by Betelgeuse, which is 1,000 times bigger than the Sun. The companion star is around four times the distance from Betelgeuse as the Earth is from the Sun, which is quite close for a stellar companion. The discovery is the first time such a close companion star has been detected orbiting a supergiant, according to a statement from the US research centre NOIRLab, which operates the Gemini Observatory. Betelgeuse is more than 10,000 times brighter than the Sun, its blinding light making spotting anything nearby difficult. Steve Howell, a Nasa scientist who led the research team, said previous 'papers that predicted Betelgeuse's companion believed that no one would likely ever be able to image it'. However the Gemini North telescope was able to spot the much smaller, dimmer star using a technique called speckle imaging. This involves assembling many images taken with short exposure times to overcome the distortions that Earth's atmosphere causes ground-bound telescopes. According to Greek myth, the giant hunter Orion claimed he would kill all the world's beasts, so Earth goddess Gaia sent a scorpion to kill him. God king Zeus then turned both Orion and the scorpion — Scorpius — into constellations. Earlier, ancient Egyptians included Betelgeuse in the constellation Osiris, their god of the dead. Even earlier, research has suggested that Indigenous Australians included Betelgeuse in their own constellations — and had noticed the star's varying brightness. — AFP
Malay Mail
6 days ago
- Malay Mail
UK births first ‘three-parent babies' in world trial to stop inherited genetic diseases
PARIS, July 17 — Eight healthy babies have been born in the UK using a new IVF technique that successfully reduced their risk of inheriting genetic diseases from their mothers, the results of a world-first trial said Wednesday. The findings were hailed as a breakthrough which raises hopes that women with mutations in their mitochondrial DNA could one day have children without passing debilitating or deadly diseases on to the children. One out of every 5,000 births is affected by mitochondrial diseases, which cannot be treated, and include symptoms such as impaired vision, diabetes and muscle wasting. In 2015, Britain became the first country to approve an in-vitro fertilisation (IVF) technique that uses a small amount of healthy mitochondrial DNA from the egg of a donor – along with the mother's egg and father's sperm. Some have called the result of this process 'three-parent babies', though researchers have pushed back at this term because only roughly 0.1 percent of the newborn's DNA comes from the donor. The results of the much-awaited UK trial were published in several papers in the New England Journal of Medicine. 'Important reproductive option' Out of 22 women to undergo the treatment at the Newcastle Fertility Centre in northeast England, eight babies were born. The four boys and four girls now range from under six months to over two years old. The amount of mutated mitochondrial DNA – which causes disease – was reduced by 95-100 percent in six of the babies, according to the research. For the other two newborns, the amount fell by 77-88 percent, which is below the range that causes disease. This indicates the technique was 'effective in reducing transmission' of diseases between mother and child, one of the studies said. The eight children are currently healthy, though one had a disturbance of their heart's rhythm which was successfully treated, the researchers said. Their health will be followed up over the coming years to see if problems arise. Nils-Goran Larsson, a Swedish reproductive expert not involved in the research, hailed the 'breakthrough'. The new technique offers a 'very important reproductive option' for families affected by 'devastating' mitochondrial diseases, he added. Ethical review Mitochondrial donation remains controversial and has not been approved in many countries, including the United States and France. Religious leaders have opposed the procedure because it involves the destruction of human embryos. Other opponents have expressed fears it could pave the way for genetically engineered 'designer babies'. An ethical review carried out by the UK's independent Nuffield Council on Bioethics was 'instrumental' in conducting the new research, the council's director Danielle Hamm said Wednesday. Peter Thompson, head of the UK's Human Fertilisation and Embryology Authority which approved the procedure, said only people with a 'very high risk' of passing on a mitochondrial disease would be eligible for the treatment. Ethical concerns have also been raised over the use of mitochondrial donation for infertility in Greece and Ukraine. French mitochondrial disease specialist Julie Stefann told AFP that 'it is a question of the risk-benefit ratio: for a mitochondrial disease, the benefit is obvious'. 'In the context of infertility, it has not been proven,' she added. Oxford University reproductive genetics expert Dagan Wells observed that 'some scientists will be a little disappointed that so much time and effort has, so far, only led to the birth of eight children'. Among the children being closely monitored are three that showed some signs of what is known as 'reversal', which is still little understood. It is 'a phenomenon where the therapy initially succeeds in producing an embryo with very few defective mitochondria, but by the time the child is born the proportion of abnormal mitochondria in its cells has significantly increased,' he explained. — AFP
